Page 11 - HFA_Dateline_2019_Q1_Spring_SpecialEdition

Current Products
on the Market

The following list of current products on the market includes: Types of Products
on the Market
Manufacturer — Company that produces and sells the therapy.
Recombinant
Product — Name used to market and sell the therapy. Clotting
Factor
Type — Indicated method used to create product (Plasma-derived, made from human 53%
blood, or recombinant factor concentrates, made from other sources).
Plasma-Derived
Half Life — Amount of time a product stays intact in the bloodstream until its Clotting Factor
efficacy is halved.
33%
FDA Approved — Year the product was approved for treatment
by the FDA.

Indications — Bleeding disorder type/factor deficiency the therapy is intended to treat.

We’ve made every effort to ensure the accuracy of the information in this list by using
information directly from manufacturers and publicly-available information from
websites, such as the FDA. HFA does not encourage community members to use one
product over another, and strongly urges you discuss your treatment options with
qualified medical professionals.

Content in this issue is current as of December 2018. Given the fast-paced
environment that manufacturers and governmental agencies work within,
some information could have changed since going to print. Please refer to

manufacturers’ or the FDA’s websites for the most up-to-date information. S

Other
14%

Special Issue 2018-19 | Dateline Federation 11